Knowledge Center
Article / Jan 01, 2011
What is Special About Inhalation APIs?
Source:
Drug Development and Delivery, January 2011
What is Special About Inhalation APIs? Drug Development Executive: Carla Vozone, Director of Business Development for Hovione's Generics Business Unit, discusses what makes Hovione unique in API supply for inhalation, its supportive technologies, and approach to the market.
Related links
Also in the Knowledge Center
/ Oct 05, 2023
Inhalable pharmaceutical composition containing spray dried cohesive composite active particles and carrier based formulation combination
Read more
Scientific Article
/ Nov 30, 2023
Webinar - Nasal powder delivery: Process, formulation and analytical characterization
Read more
Scientific Article
Scientific Article